Pagina 57 - I migliori medici in Turchia — Richiedi una consulenza online

Education and Expertise

• ISTANBUL UNIVERSITY FACULTY OF MEDICINE
• EGE UNIVERSITY FACULTY OF MEDICINE FACULTY OF MEDICINE

Diseases

• Sexually transmitted diseases
• Fungal Infections
• HIV/AIDS
• Bone and Joint Infections
• Complicated Skin Infections
• Respiratory tract infections
• Tuberculosis
• Urinary Tract Infections
• Viral Hepatitis
• Soft Tissue Infections

Experience

• 2011-2017: Research Assistant – Ege University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
• 2017-2021: Specialist Doctor – Ministry of Health, State Hospital
• 2021-2022: Specialist Doctor – Acıbadem M. Ali Aydınlar University Faculty of Medicine
• 2022-Present: Assistant Professor – Izmir University of Economics, Faculty of Medicine

Professional Memberships

• European Society for Clinical Microbiology and Infectious Diseases (ESCMID)
• Turkish Infectious Diseases and Clinical Microbiology Specialists Association (EKMUD)
• Turkish Clinical Microbiology and Infectious Diseases Association (KLİMİK)

Education and Expertise

• 2008 – 2015 – EGE UNIVERSITY FACULTY OF MEDICINE
• 2017 – 2021 – HEALTH SCIENCES UNIVERSITY TEPECİK TRAINING AND RESEARCH HOSPITAL
• 2023 – PRESENT – IZMIR ECONOMICS UNIVERSITY MEDICAL POINT HOSPITAL

Diseases

• Menstrual irregularity
• Sexual Dysfunctions
• Darkening of the external genital area
• Dysmenorrhea (Menstrual pain)
• Threat of Low
• Endometriosis
• Hirsutism (Hair Growth)
• Urinary Incontinence
• Infertility
• Gynecological Cancers
• Menopause
• Myomas

Treatment Methods

• Threat of Low
• Endometriosis Surgery
• Pregnancy Follow-up
• Genital Aesthetics
• Genital Laser Applications
• Hypnotherapy and Cupping Therapy
• Incontinence (Urinary Leakage) Surgical Treatments
• Gynecological Examination
• Labiaplasty
• Laparoscopic Hysterectomy
• Surgical Treatments for Pelvic Organ Prolapse
• Vaginismus and Sexual Therapy
• 2017 – 2021 – Izmir Tepecik Training and Research Hospital, Gynecology and Obstetrics Assistant
• 2022 – 2023 – Izmir Kemalpaşa State Hospital, Gynecology and Obstetrics Specialist Physician
• 2023 – Present – Izmir University of Economics, Medikalpoint Hospital, Gynecology and Obstetrics Specialist Physician

Professional Memberships

• Medical Aesthetics and Medicine Association- Member
• Sexual Health Institute Association- Member
• Turkish Gynecology and Obstetrics Foundation- Member
• National Association of Gynecology and Obstetrics – Member
•  

CV: Dt. Mustafa Serdar B.

Languages

English

Education

Undergraduate Education:
- Biruni University Faculty of Dentistry
- Anadolu University Health Institutions Management

Experience

2024 - Present: ClinicExpert - Dentist
2023 - 2023: Clinimed - Dentist
2023 - 2023: Now Aesthetic - Dentist
2022 - 2023: Dentalpark Dental Health Center - Dentist

Certificates

2023:
- DENTSEM Basic Implant Training
- DENTSEM Prosthesis on Implants Training
- DENTSEM Advanced Level Implantology Training
- DENTSEM Master Class in Implant Surgery
2018: Current Approaches in Periodontology
2020: EDAD 2020 Aesthetic Dentistry Congress
2018: Forensic Anthropology

CV: Dt. Ömer A.

Education

Undergraduate Education:
- 2009 - 2014: Çukurova University Faculty of Dentistry

Experience

2024 - Present: ClinicExpert - Dentist
2023 - 2024: Bakırköy 360 Dental Health Center - Dentist
2019 - 2023: Bahçeşehir Dentopia Dental Health Center - Dentist
2015 - 2023: Dentopia Oral and Dental Health Polyclinic - Dentist
2014 - 2017: Şenay Oral and Dental Health Polyclinic - Dentist

Certificates

- Prof. Dr. Uğur Erdemir: Fractured Tooth Restorations
- Prof. Dr. Aslıhan Üşümez: Porcelain Laminate Clinical Tips
- Dr. Caner Yılmaz: Dental Botox Training
- Prof. Dr. Erhan Çömlekoğlu: Digital and Traditional Fixed Prostheses Training

Association

Turkish Dental Association

Education and Expertise

• EGE UNIVERSITY FACULTY OF MEDICINE

Diseases

• Lumbar and Cervical Disc Herniation Microsurgery
• Brain Tumors
• Hydrocephalus
• Pituitary Adenoma Surgery
• Spinal Cord and Spine Surgery
• Peripheral Nerve Surgery
• Trigeminal Neuralgia
• Vascular Surgery

Experience

• 2000 – Ege University Faculty of Medicine, Department of Brain and Nerve Surgery – Specialization

Professional Memberships

• Turkish Neurosurgery Association

Education and Expertise

• 1999 – 2005 – FIRAT UNIVERSITY FACULTY OF MEDICINE
• 1995 – 1999 – IZMIR ATATURK HIGH SCHOOL

Diseases

• Alzheimer’s type dementia
• Headaches
• Dizziness
• Cerebrovascular diseases
• Vascular diseases
• Dementia Diseases
• Demyelinating Diseases
• Epilepsy
• Movement Disorders
• Migraine
• Myopathies
• MOGAD

Treatment Methods

• Botox
• Duodopa Treatment
• Intravenous Thrombolytic
• IVIG Treatment
• Migraine vaccine
• Migraine Botox

Experience

• 2005-2010 – Ege University Faculty of Medicine, Department of Neurology, Specialization Student, Izmir.
• 2010-2012 – İzmir Tire State Hospital Neurology Department
• September 2012 – May 2013 – Çanakkale 18 March University, Faculty of Medicine, Department of Neurology, Assistant Professor.
• 2013 – Medical Point Izmir Hospital Neurology Department

Professional Memberships

• Turkish Neurology Association

Education and Expertise

• 2023 BAKIRÇAY UNIVERSITY ÇİĞLİ TRAINING AND RESEARCH HOSPITAL (ASSOCIATE PROFESSOR)
• 2021 EGE UNIVERSITY FACULTY OF MEDICINE GASTROENTEROLOGY DEPARTMENT
• 2017 EGE UNIVERSITY INTERNAL MEDICINE DEPARTMENT
• 2010 EGE UNIVERSITY FACULTY OF MEDICINE

Diseases

• Liver Diseases
• Digestive System Diseases

Treatment Methods

• Endoscopy
• Endoscopic mucosal resection – EMR
• Endoscopic Obesity Treatment (Intragastric Botox, Intragastric Balloon)
• Endoscopic Polypectomy
• Endoscopic Retrograde Cholangio Pancreatography (ERCP)
• Liver Transplant
• Colonoscopy
• Peroral Cholangioscopy

Experience

• Diyarbakir 112 Emergency Health Services Chief Physician (2010-2011)
• Ege University Faculty of Medicine, Department of Internal Medicine (2012-2017)
• Ayvalik State Hospital (2017-2018)
• Ege University Faculty of Medicine, Department of Gastroenterology (2018-2021)
• Burdur State Hospital (2021-2022)
• Bakırçay University Çiğli Training and Research Hospital (2022-2024)

Professional Memberships

• 1.Turkish Gastroenterology Association (ERCP working group)
• 2. Turkish Liver Research Association
• 3. Turkish Medical Association

Education and Expertise

• 1995 – ANTALYA ANATOLIAN HIGH SCHOOL
• 2001 – HACETTEPE UNIVERSITY FACULTY OF MEDICINE
• 2008 – EGE UNIVERSITY FACULTY OF MEDICINE EAR NOSE THROAT DISEASES
• 2015 – ASSOC. PROF. DR. – IZMIR KATIP CELEBI UNIVERSITY ATATURK EDUCATION RESEARCH HOSPITAL
• 2016 – FELLOW OF EUROPEAN BOARD OF OTORHINOLARYNGOLOGY (EUROPEAN ENT COMPETENCE CERTIFICATE)

Diseases

• Allergic rhinitis
• Head and Neck Tumors
• Dizziness
• Brain fluid coming out of the nose
• Nasal Bone Curvatures
• Nasal congestion
• Nasal tumors
• Chronic Rhinosinusitis
• Ear infection
• Ear Tumors
• Eardrum perforations
• Nasal Polyp

Treatment Methods

• Head and Neck Tumor Surgery
• Endoscopic Empty Rhinorrhea Surgery
• Endoscopic Nasal Tumor Surgery
• Endoscopic Sinus Surgery
• Rhinoplasty
• Septal Perforation Repair
• Septoplasty
• Tympanomastoidectomy
• Tympanoplasty (eardrum surgery)

Experience

• 2010 – Iskenderun Military Hospital
• 2009 – 2010 – Aksaray State Hospital
• 2011 – 2023 – Izmir Katip Çelebi University Atatürk Training and Research Hospital
• 2017 – Summer School On Human Olfaction. Department of Otorhinolaryngology of the University of Dresden Medical School, Dresden, Germany.

Medical Education

School of Medicine, Adnan Menderes University

Medical Residency

Department of Cardiology, School of Medicine, Mustafa Kemal University

Areas of Interest

Invasive Cardiology.

Balloon Angioplasty & Stent Implantation for Coronary Arteries & Carotid Artery & Peripheral Arteries.

Permanent Cardiac Pacemaker Implantation (CPM, ICD, CRT).

Heart Attack (Acute Myocardial Infarction) & Heart Failure & Heart Valve Diseases & Heart Rhythm Disorders (Cardiac Arrhythmias).

Hypertension (HT) & Hyperlipidemia (HLD)

Membership

Turkish Medical Association (TTB).

Turkish Society of Cardiology (TKD).

European Society of Cardiology (ESC)

Biography

Associate Professor Koray Aykut is currently the cardiovascular surgeon of İzmir University. Previously, he was surgeon at Ege Hospital from 2008 to 2013. His specific teaching and research interests cover adult heart surgery and vascular surgery. He has authored 10 articles that are published in peer-review journals listed by SCI and SCI-e and 8 articles that are published in national journals.

Associate Professor Koray Aykut was graduated from Ege university in 1999 and completed residency of cardiovascular surgery in Dokuz Eylül University in 2005. He was cardiac surgeon in Kars State Hospital from 2005 to 2007 for compulsory service. He has been in Cyprus Army Hospital from 2007 to 2008 for his military service.

Medical Education

School of Medicine, Ege University 1993-1999

Medical Residency

Department of Cardiovascular Surgery, Dokuz Eylül University 2000-2005

School of Medicine, Izmir Democracy University

Areas of Interest

Coronary Surgery

Heart valve surgery

Aortic Surgery

Surgical correction of Congenital Heart Diseases

Peripheral Artery Surgery

Venous Surgery

Closed Surgery for Aortic Diseases

Laser-aided Surgery

Membership

Turkish Society of Cardiovascular Surgery

Turkish National Society of Vascular and Endovascular Surgery

The European Society for Cardiovascular and Endovascular Surgery

Articles

Pulsative versus non-pulsative flow to reduce cognitive decline after coronary artery bypass surgery: A Randomized prospective clinical trial.

Advanced treatment of acute femoropopliteral bypass graft occlusion with Fogarty catheter guidance.

Efficacy and Safety of Bone Wax to Reduce Sternal Bleeding Following Coronary Bypass Surgery.

Effect of Tadalafil on Neointimal Hyperplasia in a Rabbit Carotid Artery Anastomosis model

Rupture of Tricuspid Valve due to Smashing the chest into the steering wheel.

The effect of iloprost on renal ischemia/reperfusion injury in an experimental rat  

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education and Expertise

• 1989 BORNOVA ANATOLIAN HIGH SCHOOL
• UNDERGRADUATE DEGREE 1995 EGE UNIVERSITY/ FACULTY OF MEDICINE
• SPECIALIZATION IN MEDICINE 2001 DOKUZ EYLÜL UNIVERSITY/MEDICAL FACULTY INTERNAL MEDICINE DEPARTMENT
• MEDICAL SPECIALIST 2005 DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE ENDOCRINE AND METABOLISM DISEASES

Biography

Our doctor admits patients aged or older than 15.

Medical Education

School of Medicine, Ege University

Medical Residency

Department of Internal Medicine, School of Medicine, Dokuz Eylül University

Department of Endocrinology, School of Medicine, Dokuz Eylül University

Areas of Interest

Diabetes Mellitus

Thyroid Diseases

Pituitary Diseases

Hirsutism

Osteoporosis

Membership

Turkish Society of Endocrinology and Metabolism

Experience

• 2005-2009 Private Western Anatolia Central Hospital
• 2009-2011 Private Healing Hospital
• 2011-2016 Private Izmir Sifa University
• 2016-2023 Izmir Medical Point Hospital

Professional Memberships

• Turkish Medical Association
• Turkish Endocrinology and Metabolism Association

Diseases

• Lung Cancer
• Skin Cancers
• Gastrointestinal Cancers
• Genitourinary Cancers
• Gynecological Cancers
• Colon Cancer
• Breast Cancer
• Rare Cancers

Treatment Methods

• Individual Treatments (Comprehensive Genomic Profiling)
• Targeted Therapies
• Immunotherapy
• Cancer Vaccines
• Chemotherapy
• Clinical Research/Experimental Medical Research

Experience

• 2017- 2024: Katip Çelebi University Faculty of Medicine Atatürk Education and Research Hospital Medical Oncology Clinic Associate Professor / Lecturer
• 2022 December – 2023 March: Academic visitor Moffitt Cancer Center Cutaenous Oncology Clinic Tampa, Florida USA
• 2013- 2017: Katip Çelebi University Faculty of Medicine Atatürk Training and Research Hospital – Medical Oncology Clinic Specialist Physician
• 2012-2013: Izmir Education and Research Hospital, Medical Oncology Specialist Physician
• 2012-2012: Mersin State Hospital, Medical Oncology Specialist Physician
• 2010-2012: Dokuz Eylül University Faculty of Medicine, Department of Medical Oncology, Sub-branch Research Assistant
• June-August 2008, December 2008 – February 2009: Memorial Sloan Kettering Cancer Center Observership programme
• 2007-2009: Kartal Education and Research Hospital, Medical Oncology Sub-branch Research Assistant
• 2006-2007: Siirt State Hospital, Internal Medicine, Specialist Physician
• 2005-2006: Çukurova University Faculty of Medicine, Medical Oncology Sub-branch Research Assistant
• 2004-2005: SSK Siirt Hospital, Internal Medicine Specialist Physician
• 2003-2004: SSK Mardin Hospital, Internal Medicine Specialist Physician
• 1998-2003: SSK Izmir Training and Research Hospital, 3rd Internal Medicine Clinic, Research Assistant
• 1998-1998: SSK Izmir Training and Research Hospital Infectious Diseases Research Assistant
• 1997-1998: Izmir Ataturk Training and Research Hospital, Anesthesiology and Reanimation Clinic, Research Assistant
• 1995-1997: Şırnak Cizre Central Health Center
• 1994-1995: Şırnak İdil Oyalı Village Health Center

Professional Memberships

• Turkish Society of Medical Oncology 2008 
• (2018-2021 Term Board Member)
• Izmir Oncology Group, Board Member (2014 -…)
• Geriatric Oncology Association, Board Member (2015-…)
• Mediterranean Oncology Association Board Member (2020 -…)
• Turkish Biochemistry Association, Member, 2016
• European Society of Medical Oncology, Member, 2012
• American Society of Clinical Oncology, Member, 2008

Education and Expertise

• HACETTEPE UNIVERSITY FACULTY OF MEDICINE

Diseases

• Endometriosis – Advanced stage
• Endometrium
• Advanced Ovarian Cancer
• Myoma uteri diseases
• Ovarian cysts
• Benign diseases of the uterus

Treatment Methods

• Hypothermic intraperitoneal chemotherapy
• Laparoscopy
• Minimally invasive operations
• Cytoreductive surgery
• Vulva aesthetics

Experience

• 2001 – Ankara Etlik Training and Research Hospital, Department of Obstetrics and Gynaecology
• 2011 – Medical Specialization Board Gynecological Oncology Surgery

Professional Memberships

• European Society of Gynaecological Oncology
• Minimally Invasive Gynecologic Oncology Association
• Cervical Pathology and Colposcopy Association
• Turkish Obstetrics and Gynecology Association
• Turkish Gynecological Oncology Association
• Society of Robotic Gynecological Surgery
• Turkish Medical Association
• Pelvic Pain and Endometriosis Association

Education and Expertise

• EGE UNIVERSITY FACULTY OF MEDICINE, IZMIR 2000 – 2006 UNDERGRADUATE EDUCATION
• EGE UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF GENERAL SURGERY, IZMIR, 2006 -2012 RESEARCH ASSISTANT SPECIALIST TRAINING
• ISTITUTO NAZIONALE DEI TUMORI, MILAN 2010 VISITING FELLOW ONCOLOGICAL SURGERY

Diseases

• Liver tumors and metastases
• Pancreatic diseases
• Gallbladder diseases
• Digestive system tumors
• Digestive system diseases

Treatment Methods

• Adrenal gland tumor surgeries
• Liver metastasis surgeries
• Liver resections
• Lymph node dissections around aorta in my Lend metastases
• Bile duct resections and reconstructions
• Alimentary tract surgeries

Experience

• 2010: Istituto Nazionale dei Tumori, Milan – Tumor surgery training
• 2013 – 2016: Denizli State Hospital – Compulsory Public Service
• 2016 – 2020: Izmir University of Economics, Faculty of Medicine, Founding Lecturer
• August 2020: Associate Professor of General Surgery
• 2016 – 2021 Kent Hospital Liver Transplantation Unit – Liver transplantation and liver surgery training
• 2021 – Present: IUE Medical Point Hospital, Department of General Surgery

Professional Memberships

• Turkish Medical Association – 2006
• Turkish Surgical Association – 2013
• Denizli Surgery Association – 2013 (Founding member)
• International Liver Transplantation Society – 2016

Prof. Ramazan Gökhan ATIŞ, M.D.

Languages: English

Urology

Areas of Expertise and Interest

• Paediatric Urology
• Robotic Surgery
• Endourology
• Genitourinary Reconstructive Surgery
• Urological Oncology
• Urological Neurology
   

Education

• Cağaloğlu Anatolian High School, Istanbul – Graduated in 1996
• Istanbul University, Istanbul Faculty of Medicine (Çapa) – M.D., 2002
• Urology Residency, Istanbul Şişli Etfal Training and Research Hospital – 2002–2008
• Laparoscopy and Robotic Urology Training, Heidelberg University, Heilbronn Clinic – 2011

Career

• Urology Specialist, Istanbul Göztepe Training and Research Hospital – 2009–2014
• Associate Professor Title Achieved – September 2014
• Executive Board Member, Endourology Society – Since 2017
• Member, European Association of Urology – Young Academic Urologists (EAU-YAU), Endourology Working Group – 2018–2020
• Professor of Urology, Istanbul Medeniyet University – Appointed in January 2021
• Urologist, Şişli Memorial Hospital – Since August 1, 2022
   

Born in 1978 in Istanbul, Prof. Dr. Ramazan Gökhan ATIŞ completed his medical degree at Istanbul University’s Faculty of Medicine in 2002. He pursued his urology specialization at Şişli Etfal Training and Research Hospital and became a certified urologist in February 2008. Following his military service at Edremit Military Hospital, he began working at Göztepe Training and Research Hospital in 2009.

In 2011, he received training in laparoscopic and robotic urology at Heidelberg University’s Heilbronn Clinic. Between 2009 and 2014, he conducted numerous scientific studies, especially in the field of endourology, earning the title of Associate Professor in 2014.

Since 2017, he has served on the board of the Endourology Society. In 2018, he was selected to the European Association of Urology’s Young Academic Urologists (EAU-YAU) Endourology Working Group, actively serving for two years. In January 2021, he was appointed as a Professor at Istanbul Medeniyet University. Since August 1, 2022, he has continued his clinical practice, initially at Şişli Memorial Hospital and currently at Medipol Acıbadem District Hospital.

Dr. Namik Ozkan is an experienced General Surgery Specialist at Memorial Ankara Hospital. He has served as Professor and Dean of the Faculty of Medicine at Tokat Gaziosmanpaşa University and Aksaray University. He was also the founding dean at Aksaray University.

Dr. Ozkan has over twenty years of clinical and teaching experience in hospitals and universities across Turkey. He completed his medical degree and specialization at Ankara University Faculty of Medicine. His leadership and faculty roles show his strong commitment to medical education and general surgery.

Dr. Ayse Callioglu is a dermatologist. She focuses on dermal fillers, facial lifting, rhinoplasty (nose aesthetics), chemical peels, acne treatment, and Botox.

Education: Ege University Faculty of Medicine. Akdeniz University Faculty of Medicine.

Clinical experience includes Private Anadolu Hospital and Medstar Hospital. She has also worked at Lara Yaşam Hospital and Medical Park Antalya.

Accreditations/Memberships: Turkish Society of Dermatology and Mediterranean Society of Dermatology. International Society of Cosmetic Dermatology and European Academy of Dermatology and Venereology.

Dr. Kahraman Ahmet Salih Emri is a pulmonologist with over 30 years of experience. He has worked at respected institutions such as Hacettepe University, Medicana Kızıltoprak Hospital, Florence Nightingale Hospital, and Memorial Bodrum Hospital. He completed his subspecialty training in pulmonology and his specialization in internal medicine at Hacettepe University Faculty of Medicine.

Dr. Emri is a member of several professional organizations, including the Turkish Medical Association, Turkish Thoracic Society, Turkish Respiratory Society, International Association for the Study of Lung Cancer, International Mesothelioma Interest Group, and Turkish Lung Cancer Society. He has contributed to international research, including work at Boston University Oncology and Neurology Clinics. He has also attended many professional trainings and conferences during his career.